← Open Payments lookup

JENNIFER LEE: Open Payments

NPI 1871927574 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,382 in 32 payments from 11 companies in 2025. Trend: 2023 $250 · 2024 $977 · 2025 $1,382

Food & beverage: $1,382
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$290
ABBVIE INC.10$220
Supernus Pharmaceuticals, Inc.5$177
E.R. Squibb & Sons, L.L.C.3$167
Neurocrine BioSciences, Inc.2$150
Axsome Therapeutics, Inc.1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$122
Janssen Pharmaceuticals, Inc3$68
Lundbeck LLC1$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21

Products named: REXULTI, VRAYLAR, Qelbree, COBENFY, INGREZZA, Auvelity, CAPLYTA, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.